Quick Answer
Emmaus Life Sciences, Inc. reported Net Income of -$7.49 million for fiscal year 2025.
Emmaus Life Sciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.49M | -16.1% |
| 2024 | -$6.45M | -72.9% |
| 2023 | -$3.73M | +64.9% |
| 2022 | -$10.62M | +33.4% |
| 2021 | -$15.95M | -1277.7% |
| 2020 | $1.35M | +102.5% |
| 2019 | -$54.84M | +24.4% |
| 2018 | -$72.59M | -656.2% |
| 2018 | -$9.60M | -34.9% |
| 2017 | -$7.11M | -19.7% |
| 2016 | -$5.94M | -75.8% |
| 2015 | -$3.38M | -26.9% |
| 2014 | -$2.66M | +75.6% |
| 2013 | -$10.91M | -220.2% |
| 2012 | -$3.41M | +61.6% |
| 2011 | -$8.87M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.08M | -213.6% | -82.9% |
| June 30, 2025 | -$1.14M | +48.0% | +51.3% |
| March 31, 2025 | -$2.33M | +46.4% | -227.5% |
| September 30, 2024 | $1.83M | +2626.9% | +183.7% |
| June 30, 2024 | -$2.18M | -40.2% | +49.8% |
| March 31, 2024 | -$4.35M | -26.0% | -6589.6% |
| September 30, 2023 | $67.0K | +117.1% | +104.3% |
| June 30, 2023 | -$1.56M | +82.5% | +54.9% |
- Emmaus Life Sciences, Inc. showed a decrease of -16.1% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, Emmaus Life Sciences, Inc.’s net income has grown by 15.5% (from -$8.87 million to -$7.49 million).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: